Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03194256 · ClinicalTrials.gov registry record · NA

Evaluating New Nicotine Standards for Cigarettes - Project 3

A NA study, sponsored by Brown University.

Completed
Registry status
NA
Development phase
80
Enrollment target

NCT03194256: Completed NA study, sponsored by Brown University.

NCT03194256 is a NA study that has completed, run by Brown University. The registered enrollment target is 80 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03194256, a NA study, has completed, sponsored by Brown University.

COMPLETED
Registry status
NA
Development phase
80 participants
Enrollment target

Study Summary

This study is designed to examine how the nicotine content of cigarettes and the nicotine concentration and flavors in e-liquids influence responses to and use of these products in adolescent smokers. Participants will complete a total of six sessions (an in-person screening/baseline session and five lab sessions.

Primary Outcome

The number of cigarette puffs selected during a 30 minute choice procedure when no vaping device was available

Interventions

  • BEHAVIORAL Spectrum Research Cigarettes

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2018-09-01
Est. Completion 2022-11-30
Phase NA
Brown University

231 total trials

What the finished NCT03194256 record still lists

NCT03194256 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).

The record links to 0 conditions, and to 1 intervention - of which Spectrum Research Cigarettes is the first listed.

NCT03194256 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03194256 about?

NCT03194256 is a clinical study titled "Evaluating New Nicotine Standards for Cigarettes - Project 3". This study is designed to examine how the nicotine content of cigarettes and the nicotine concentration and flavors in e-liquids influence responses to and use of these products in adolescent smokers. Participants will complete a total of six sessions (an in-person screening/baseline session and fiv...

What is the current status of trial NCT03194256?

This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2018-09-01. Estimated completion is 2022-11-30.

What interventions are being tested in trial NCT03194256?

The interventions under investigation include: Spectrum Research Cigarettes (BEHAVIORAL).

Who is sponsoring clinical trial NCT03194256?

This trial is sponsored by Brown University, which has 231 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03194256's enrollment target sits among peer trials

80 994th of 2000 higher than 941 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01243931 · 80 participants · NA

    Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy

  • NCT01659203 · 80 participants · Phase 1

    Proton or Photon RT for Retroperitoneal Sarcomas

  • NCT01803451 · 80 participants · Early Phase 1

    Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass

  • NCT01964859 · 80 participants · Phase 2

    Feasibility Study for Fibroblast Autologous Skin Grafts

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03194256, the US trial registry maintained by the National Library of Medicine. NCT03194256 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.